Background and Purpose-The relationship of cortical and subcortical cerebral atrophy to cerebral microvascular disease is unclear. We aimed to assess the associations of retinal vascular signs with cortical and subcortical atrophy in patients with acute stroke. Methods-In the Multi-Centre Retinal Stroke Study, 1360 patients with acute stroke admitted to 2 Australian and 1
have detailed MRI phenotypic assessment so that differences between cortical and subcortical cerebral atrophy cannot be fully investigated in population-based studies.
Small vessel disease in the brain has been increasingly recognized to be one of the most prevalent neurological disorders and is also associated with aging. 13 Recent studies using the retinal circulation as a surrogate for cerebral microcirculation have documented associations between vascular signs in the retina and various brain pathologies. 14, 15 The Atherosclerosis Risk and Communities (ARIC) study of 1684 healthy middle-aged persons suggested that participants with cortical and subcortical atrophy were more likely to have retinopathy than those without cerebral atrophy. 16 However, whether similar associations are present in acute stroke cases with cortical and subcortical atrophy is unclear. Other retinal microvascular signs such as focal retinal arteriolar narrowing, arteriovenous nicking, and arteriolar wall light reflex have not been assessed for their specific associations with cerebral atrophy. In this study, we aimed to examine whether differential patterns of associations are present for retinal vascular signs in cortical compared with subcortical cerebral atrophy in patients with acute stroke.
Materials and Methods

Study Population
The Multi-Centre Retina & Stroke (MCRS) Study is a prospective hospital-based cross-sectional study. The study population, study design, and methods of the MCRS are described in detail elsewhere. 17 In brief, 1565 participants, aged 19 to 94 years, were prospectively recruited from stroke units at Westmead Hospital, Sydney (nϭ280), Royal Melbourne Hospital, Melbourne (nϭ562), and Singapore General Hospital (nϭ723) within 7 days of acute stroke (first or recurrent events) during 2005 to 2007. Participating patients underwent an interview with standardized questionnaires, neurological examination, neuroimaging, and retinal photography. Written informed consent was obtained from patients or their next of kin. The MCRS was approved by the Human Research Ethics committees of the respective hospitals. In the present study, we included 1360 acute stroke cases after excluding 43 cases classified as stroke mimic, 93 as transient ischemic attack, and 69 with ungradable images.
Assessment of Acute Stroke
A final consensus diagnosis of acute stroke-definite, probable, or possible-was made for each patient by a panel of stroke experts with access to the clinical information and neuroimaging findings. We included all definite, probable, or possible stroke cases in this report. All patients had CT brain scanning, and a large subset also had MRI scanning. 17 The finding of a hyperdense intraparenchymal or intraventricular lesion on CT (that was not determined to be calcium) led to a diagnosis of intracranial hemorrhage (lobar or deep intracranial hemorrhage differentiated by location); hemorrhagic transformation of an infarct was coded as a cerebral infarct; and intracranial hemorrhage due to secondary causes such as trauma, neoplasm, or arteriovenous malformation was excluded. The ischemic stroke subtypes were classified into 5 core etiologic groupings: large vessel atherosclerosis; small vessel (lacunar); cardioembolic infarction; stroke of other etiology; and stroke of undetermined etiology or competing causes determined from a pragmatic modification of the Trial of Org 10172 in Acute Stroke Treatment classification (Appendix, copied from the methodology article of this study 17 ) as adopted by the Greater Metropolitan Clinical Taskforce for Stroke in New South Wales, Australia. 18 Patients only proceeded to MRI according to their attending clinician. In general, patients with large vessel disease had demonstrated large artery stenosis. Lacunar stroke was defined on CT brain scan as a small rounded lesion with lower attenuation than normal brain but with higher attenuation than cerebrospinal fluid in the subcortical white matter, basal ganglia, pons, or brain stem and no greater than 20 mm diameter. On MR brain scan, this was defined as an area of increased signal on T2-weighted and fluid-attenuated inversion recovery images with respect to normal brain but not of cerebrospinal fluid signal with no hemosiderin in the lesion (to suggest primary hemorrhage) on gradient echo and a maximum permitted diameter of 20 mm. Lacunar infarction on MRI-positive diffusion-weighted imaging was defined as high signal diffusionweighted imaging with reduced signal on the apparent diffusion coefficient map with or without a corresponding lesion present on structural MRI. Cardioembolic infarction was defined to include atrial fibrillation, intracardiac thrombus or tumor, rheumatic mitral stenosis, prosthetic valves, endocarditis, sick sinus syndrome, left ventricular aneurysm or akinesia after acute myocardial infarction, acute (Ͻ3 months) myocardial infarction, and cardiomyopathy in the absence of another etiology. In this report, we used 2 major ischemic stroke subtypes, lacunar in 1 group and all other remaining ischemic strokes in a second group, termed nonlacunar infarction.
White matter lesions were defined as bilateral or patchy subcortical hypodensities not discernible as a clearcut infarct on CT or as hyperintensities on T2-weighted and fluid-attenuated inversion recovery MRI images. However, they were not as hyperintense as cerebrospinal fluid on T2-weighted and not cerebrospinal fluid intensity on fluid-attenuated inversion recovery to distinguish them from lacunes (if Ն3 mm in diameter) and enlarged perivascular spaces (if Ͻ3 mm diameter).
Assessment of Cortical and Subcortical Cerebral Atrophy
Cortical and subcortical atrophy were graded on CT (as well as MRI in a subset [40%] of patients) by stroke physicians masked to patients' retinal image grading according to a set of CT reference standards 19 based on a standardized atrophy classification system devised to visually rate global cerebral atrophy and to distinguish superficial cortical from deep white matter subcortical atrophy. This was initially based on experience with the Wahlund atrophy scale 20 but was extended to differentiate superficial from deep atrophy and for use with CT and MR images. This approach was recently validated in a range of older aged persons. 21 Kappa value for the intragrader reproducibility between CT and MRI in our study sample was 0.68.
Retinal Photography and Grading
The retinal photography procedures used in this study are described elsewhere. 17 Briefly, up to 6 retinal photographs of each eye were taken, following diabetic retinopathy study fields 1 to 6, 22 using a nonmydriatic digital camera (Canon D60; Canon, Tokyo, Japan), usually after pharmacological pupil dilatation.
Focal retinal signs, including retinopathy lesions (microaneurysms, cotton wool spots, retinal hemorrhages, and hard exudates) were graded as either present or absent. Retinal arteriolar wall signs were graded as absent, mild, or severe for focal arteriolar narrowing, arteriovenous nicking, and enhanced arteriolar light reflex. The grading was performed by comparison with a standard set of images for various retinal microvascular signs, as previously described. 23, 24 All lesions detected were adjudicated by a senior researcher (J.J.W.), and cases that had pathologies other than retinal vascular wall signs were further adjudicated by a retinal specialist (P.M.).
Quantitative retinal vessel signs were graded at the Centre for Eye Research Australia, which included estimates of retinal arteriolar and venular caliber, using a semiautomated computer-assistant method. The Parr-Hubbard-Knudtson formula 25 
Vascular Risk Factors
Patients underwent an extensive assessment of atherosclerotic diseases and vascular risk factors during their admission. 17 In brief, hypertension was diagnosed according to a self-reported history or the use of antihypertensive medication. Diabetes was diagnosed as a fasting glucose Ն7.0 mmol/L or a self-reported history of diabetes, which included use of oral hypoglycemic agents or insulin. Coronary heart disease and myocardial infarction were ascertained by an adjudication process involving medical history, physical examination, and laboratory criteria, including an electrocardiogram.
Statistical Methods
Logistic regression models were constructed to assess the associations of various retinal vascular signs (independent variables) with cortical, subcortical atrophy, or both (dependent variables) compared with patients with acute stroke without any cerebral atrophy. Models were adjusted for age, gender, study site, hypertension, hypercholesterolemia, diabetes, and cigarette smoking status. Forty patients were assessed as having dementia. Supplemental analyses were performed after excluding these 40 patients. Subgroup analyses were also performed stratified by the presence of hypertension, diabetes and the 2 major ischemic stroke types (lacunar and nonlacunar infarction). Relatively small numbers in other acute stroke subtypes did not permit analyses to be conducted for each of these. ORs and 95% CIs are reported.
Results
Cerebral atrophy was present in 771 of 1360 patients with acute stroke (56.7%), of whom 203 (26.3%) had isolated cortical atrophy, 144 (18.7%) had isolated subcortical atrophy, and 424 (55.0%) had both atrophy subtypes. Patient characteristics and vascular risk factor profiles or those with cortical atrophy, subcortical atrophy, both subtypes, or no cerebral atrophy (nϭ589) are shown in Table 1 . Patients with either or both cerebral atrophy types were significantly older, more likely to give a history of previous stroke, angina, or myocardial infarction, and to copresent with either dementia or atrial fibrillation. Among patients with cortical atrophy, Ͼ50% were white and approximately one third were Chinese. Among patients with subcortical atrophy, 39% and 46% were white and Chinese, respectively. In addition, patients with subcortical atrophy were more likely to have smoked in the past but were less likely to be current smokers. Patients with both atrophy subtypes were more likely than patients without cerebral atrophy to have dementia or a history of cancer (Table 1) . The frequencies of acute stroke subtypes (defined using the modified Trial of Org 10172 in Acute Stroke Treatment criteria) and other cerebrovascular diseases in patients with either isolated cortical or subcortical atrophy, both atrophy subtypes, or those with no cerebral atrophy are shown in Table 2 . Compared with patients without cerebral atrophy, those with atrophy (either cortical or subcortical or both subtypes) were more likely to have an ischemic stroke of cardioembolic etiology plus white matter lesions. Patients with isolated cortical atrophy were less likely to have lacunar infarction, whereas the majority (60% to 70%) of patients with either isolated subcortical atrophy or with both atrophy subtypes were more likely to have white matter lesions (Table 2) .
Compared with patients with acute stroke without cerebral atrophy, those with isolated cortical atrophy were not significantly more likely to have retinal vascular signs. However, patients with isolated subcortical atrophy or with both atrophy subtypes were significantly more likely to have retinopathy lesions (OR, 1.9; CI, 1.2 to 3.0) or enhanced arteriolar light reflex (OR, 2.0; CI, 1.2 to 3.2) after adjusting for age, gender, study site, hypertension, hypercholesterolemia, diabetes and smoking status (Table 3) . These associations were similar across 3 ethnic groups (whites, Chinese, others, data not shown). After excluding the 40 patients classified as having dementia, the association of retinopathy (OR, 1.9; 95% CI, 1.2 to 3.0) or enhanced arteriolar light reflex (OR, 1.9; 85% CI, 1.2 to 3.0) with subcortical atrophy remained. In subgroup analyses stratified by hypertension, adjusting for the same variables (except for hypertension), as those in the model in Table 3 , the associations of subcortical atrophy with retinopathy or enhanced arteriolar light reflex were only evident in patients with a history of hypertension (OR, 2.6; 95% CI, 1.5 to 4.6 for retinopathy and OR, 2.5; 95% CI, 1.4 to 4.3 for enhanced arteriolar light reflex; Table 4 ), but not in patients without hypertension (OR, 1.1; 95% CI, 0.5 to 2.6 and OR, 0.9; 95% CI, 0.4 to 2.4 for these 2 retinal lesions, respectively).
In analyses stratified by the presence of diabetes, adjusting for the same covariables (except for diabetes) as those in the model in Table 3 , the associations were similar in the 2 subgroups but were significant only in the group without diabetes (OR, 1.9; 95% CI, 1.0 to 3.4 for retinopathy and OR, 2.0; 95% CI, 1.1 to 3.8 for enhanced arteriolar light reflex; Table 5 ) and were nonsignificant in patients with diabetes (OR, 1.8; 95% CI, 0.9 to 3.7 for retinopathy and OR, 1.9; 95% CI, 0.9 to 3.9 for enhanced arteriolar light reflex). In addition to these associations, patients without diabetes, with isolated subcortical atrophy, were also more likely to have retinal venular widening (Table 5 ).
In analyses stratified by lacunar (Nϭ395 cases) and nonlacunar infarction (Nϭ860 cases), adjusting for the same covariables as those in the model in Table 3 , the associations of retinopathy (OR, 2.4; 95% CI, 1.4 to 4.3) and enhanced arteriolar light reflex (OR, 2.4; 95% CI, 1.3 to 4.6) with subcortical atrophy were evident in only patients with nonlacunar infarction, but not in those with lacunar infarction (OR, 1.2; 95% CI, 0.5 to 3.0 and OR, 1.5; 95% CI, 0.5 to 3.7 for the 2 retinal lesions, respectively). In the lacunar infarction subgroup, subcortical atrophy was significantly associated with retinal venular widening (OR, 2.8; 95% CI, 1.2 to 6.6). This association was not evident in patients with nonlacunar infarction (OR, 0.7; 95% CI, 0.3 to 1.5).
Discussion
In this study that includes Ͼ1300 patients recruited after an acute stroke event, we documented associations with 2 retinal vascular signs (retinopathy and enhanced arteriolar wall light reflex) and subcortical cerebral atrophy. However, we did not identify any retinal vascular signs that were associated with cortical atrophy. These observed associations of the retinal vascular signs with subcortical atrophy remained after excluding patients with dementia. In stratified analyses, the associations were evident only in patients with hypertension. This could be due to a greater prevalence of pathology, for example, small vessel disease, in patients with hypertension. Our findings support the concept that cortical and subcortical cerebral atrophy may have a differential pathophysiology and that subcortical atrophy is related to cerebral small vessel disease or microvasculopathy. 
Baker et al Cerebral Atrophy and Retinal Vascular Signs 2147
Our findings are consistent with the previous ARIC study report, 16 which examined a generally healthy populationbased sample and found that retinopathy lesions were associated with cortical and subcortical atrophy, independent of age, gender, race, blood pressure, cigarette smoking, common carotid artery intima-media thickness, and other vascular risk factors. 16 Small vessel disease in the brain is now recognized as a common neurological disorder, particularly in aged persons. 13 Although our findings provide support for the concept that small vessel disease in the brain (using the surrogate of retinopathy and enhanced light reflex in the retina) plays a role in subcortical atrophy, 26 the precise sequence of events leading to cerebral small vessel disease is not clear. Pathologists have proposed at least 5 distinct entities that can cause damage to small-caliber vessels in the brain: (1) an intrinsic arteriolar wall abnormality termed lipohyalinosis (a destructive wall lesion containing mural foam cells and fibrinoid necrosis in some acute lesions) 27 ; (2) a concentric thickening of the hyaline wall seen termed hyaline arteriosclerosis, commonly in old age; (3) amyloid angiopathy (caused by neuron-derived ␤-amyloid infiltration into the endothelial wall) 28 ; (4) insidious endothelial (blood-brain barrier) dysfunction 29 ; and (5) other rare causes. 30 Retinopathy is less frequent in the general population (7% to 11%) 15 compared with patients with acute stroke (prevalence ranged from 33.4% in nonlacunar cerebral infarction to 39.8% in intracerebral hemorrhage). The retinopathy prevalence was particularly high in patients with acute stroke with subcortical atrophy (44.2%), whereas there was no significant difference in prevalence between cortical atrophy (27.5%) patients and those without cerebral atrophy (32.2%). Possible disruption of the blood-brain barrier in the cerebral microcirculation, analogous to the disruption of blood-retina barrier, is suggested by the presence of retinopathy lesions 31 and could be a distinct pathological feature in the development of subcortical atrophy. The most frequent retinopathy lesions are microaneurysms and retinal hemorrhages. 32, 33 Disruption of the blood-brain barrier could result in a leakage of serum components (ie, plasmin or other proteases, environmental toxins carried in the blood, infectious agents, altered electrolyte levels) into the brain through small vessel walls, resulting in perivascular edema and thus cerebral matter injury. 34 Our data showed different frequencies of a number of important and interesting vascular factors in persons with cortical, subcortical and diffuse (both cortical and subcortical) atrophy (Table 1) . As expected, our study confirmed an association between dementia and cerebral atrophy (prevalence of dementia was 4.0% among patients with cortical atrophy, 4.9% in those with subcortical atrophy, 5.2% in those with both, and only 0.5% in those with none; Table 1 ). Our study findings suggest additional pathophysiological mechanisms in support of recent concepts of vascular dementia and that the pathogenesis of Alzheimer dementia extends beyond aging to include oxidative and inflammatory damages to the brain and its microvasculature. 35, 36 Some other differences such as a history of cancer are likely due to the older age of patients with cerebral atrophy, because adjustment for age eliminated this association (data no shown). Finally, the significance of wider retinal venular caliber in patients with subcortical atrophy and without diabetes is unclear, but it is consistent with previous associations of wider retinal venular caliber with generalized small vessel disease such as the presence of white matter lesions, 37, 38 increased risk of stroke, 39, 40 cerebral hypoxia, reduced small vessel arteriolar compliance, endothelial dysfunction, hyperglycemia, inflammation, 41, 42 and dilatory effects of ␤-amyloid deposition on vascular tone. 43 The strengths and weaknesses of the MCRS have been detailed elsewhere. 44 Our assessments of cerebral atrophy from MRI, and retinal signs from photographs, were made by observers "masked" to the other assessments and to clinical details. For cerebral atrophy, the rating was "masked" in the sense that those grading the brain imaging made these ratings from the neuroimaging data rather than from their clinical assessment of patients, and they were blind to the retinal analyses. Although some atrophy signs could be affected by a very large infarct, this would not substantially affect any association with retinal vascular signs. The retinal signs were assessed from photographs by "masked" graders, who had no access to any clinical information about the patients or about their MRI assessments.
A number of important limitations of this study may have influenced our study findings. First, there is a possibility of misclassification of cerebral atrophy cases because variation in brain morphology between individuals increases significantly with increasing age, resulting in a wider range of "normal" images at extremes of age. 21 We did not adjust for peak brain volume, a surrogate for intracranial volume, or evaluate associations by specific regions of atrophy, but used global ratings of cortical and subcortical atrophy. 45 However, these visual scales automatically adjust for overall head size because the eye adjusts for how much the brain has shrunk relative to the skull. Some investigators have suggested that the temporal and occipital regions are more vulnerable than other regions to the effects of vascular disease. 9 Second, there are currently limited methods for grading cerebral atrophy, and the method we used, although reliable, is simple and therefore effective for use in large-scale studies. Cortical and subcortical atrophy were graded on CT (using a set of 3 CT brain templates for cortical and subcortical atrophy, respectively) and on MRI in a subset (using the same CT brain templates where we selected the nearest likeness as seen on MRI), and this method has been validated for MR and CT interchangeably. We used only dichotomous definitions for the presence or absence of cortical and subcortical atrophy and avoided using quantitative estimation for severity. Third, our study has insufficient power to assess differences in the associations of retinopathy lesion subtypes with cerebral atrophy across most acute stroke subtypes. Finally, longitudinal data are needed to determine whether retinal microvascular signs and subcortical atrophy occur concurrently.
Conclusion
Patients with acute stroke with cortical and subcortical atrophy differ in their prevalence of presenting retinal vascular signs. Cortical atrophy was not associated with any retinal vascular signs, whereas subcortical atrophy was associated with retinopathy, indicating blood-retina barrier breakdown. These data support the concept of a distinct microvasculopathy or small vessel disease underlying subcortical atrophy.
